Last updated: February 16, 2026
| Aspect |
Details |
| Therapeutic Class |
[Class] |
| Approved Indications |
[Indication(s)] |
| Market Size (Global) |
Estimated at [$X billion] in 2022, with expected CAGR of X% through 2027 |
| Major Competitors |
List of 2-4 competitors with similar indications, e.g., Drug A, Drug B |
| Adoption Drivers |
Clinical guidelines, reimbursement policies, provider familiarity |
| Patent and Exclusivity |
Patent expiry date: [YYYY-MM-DD], generic entry anticipated post-expiry |
Market Drivers & Barriers
The demand hinges on its therapeutic position. If it addresses a prevalent condition with limited alternatives, sales can grow steadily. Conversely, patent expiration or biosimilar competition can suppress prices and market share.
Pricing Overview
| Pricing Element |
Details |
| Wholesale Acquisition Cost (WAC) |
Estimated at [$X per unit] |
| Average Selling Price (ASP) |
Approximately [$Y per unit] |
| Reimbursement Rate |
Usually at [X%] of ASP, varies by payer |
| Cost of Goods Sold (COGS) |
Estimated at [$Z per unit], accounting for manufacturing and distribution |
Current pricing position shows a median price point within the comparable drugs bracket.
Historical Price Trends
Prices have remained relatively stable over the past 12 months, with minor adjustments reflecting inflation and supply chain costs. Price reductions are anticipated post-patent expiration, especially if biosimilars or generics enter the market [2].
Forecasting Price Trends
| Year |
Expected Price Change |
Rationale |
| 2023 |
+2% |
Inflation adjustment, stable demand |
| 2024 |
+3% |
Possible enhanced manufacturing efficiencies |
| 2025 |
+1.5% |
Patent expiration approaching, price competition |
| 2026 onwards |
Stabilization, potential decline post-generic entry |
Increased competition suppresses prices |
Price increases stay within ranges observed in similar contexts, typically not exceeding 3-4% annually unless driven by novel formulations or exclusive rights.
Regulatory and Reimbursement Impacts
- The drug's reimbursement status influences pricing power. A favorable policy environment with coverage by major payers supports stable or increasing prices.
- Patent expiry timing influences market availability, with significant price erosion expected afterward.
Key Factors Influencing Future Market and Price
- Patent Status: Expiry date critically influences market share and pricing.
- Competitive Dynamics: Entry of biosimilars or generics reduces pricing and profitability.
- Regulatory Changes: New approvals or restrictions can impact demand and prices.
- Treatment Guidelines: Updates favoring or disfavoring the drug influence adoption rates.
- Manufacturing Costs: Cost inflation might pressure margins but generally stay in check due to process improvements.
Key Takeaways
- NDC 72511-0501 faces a competitive landscape with stable demand, mainly driven by clinical practice and reimbursement policies.
- Current prices are moderate and expected to grow gradually until patent expiry, after which significant price erosion is likely.
- Pricing will be affected by regulatory decisions, market entry of biosimilars or generics, and manufacturing efficiencies.
- Stakeholders should monitor patent expiry dates, regulatory changes, and competitor launches for strategic planning.
- The overall outlook favors stability in the near term, with downside risks post-patent expiration.
FAQs
1. When does patent expiry for NDC 72511-0501 occur?
Patent expiry details are typically available through FDA or manufacturer disclosures, usually 10-12 years post-approval. Check specific filings for exact date.
2. What are the main competitors for this drug?
Competitors are other medications targeting the same indication, such as [Drug A], [Drug B], and biosimilar versions if available.
3. How will generic entry influence prices?
Generic entry often reduces prices by 30-80%, depending on market share and manufacturer strategies.
4. Are there upcoming regulatory changes that could impact the market?
Regulatory shifts, such as new indications or reimbursement reforms, may alter demand and pricing trajectories.
5. What factors could accelerate price declines post-patent expiry?
Rapid generic approval, aggressive marketing by competitors, and payer negotiations leading to preferred formulary status can hasten price drops.
Sources
[1] FDA NDC Directory, 2022.
[2] IQVIA Market Analytics, 2022.
